As of 2024-12-15, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 39.75 USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.01 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -39.8%.
The range of the Relative Valuation is 25.52 - 55.27 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 32.7x | 30.6x |
| Forward P/E multiples | 22.8x - 38.3x | 24.8x |
| Fair Price | 25.52 - 55.27 | 39.75 |
| Upside | -61.3% - -16.3% | -39.8% |
| Date | P/E |
| 2024-12-13 | 39.03 |
| 2024-12-12 | 39.18 |
| 2024-12-11 | 39.01 |
| 2024-12-10 | 39.28 |
| 2024-12-09 | 39.51 |
| 2024-12-06 | 39.47 |
| 2024-12-05 | 39.12 |
| 2024-12-04 | 39.33 |
| 2024-12-03 | 37.37 |
| 2024-12-02 | 38.46 |
| 2024-11-29 | 39.05 |
| 2024-11-27 | 38.68 |
| 2024-11-26 | 38.37 |
| 2024-11-25 | 38.49 |
| 2024-11-22 | 38.00 |
| 2024-11-21 | 37.52 |
| 2024-11-20 | 36.99 |
| 2024-11-19 | 36.64 |
| 2024-11-18 | 36.62 |
| 2024-11-15 | 37.50 |
| 2024-11-14 | 38.79 |
| 2024-11-13 | 39.42 |
| 2024-11-12 | 39.10 |
| 2024-11-11 | 39.25 |
| 2024-11-08 | 39.66 |
| 2024-11-07 | 39.58 |
| 2024-11-06 | 39.12 |
| 2024-11-05 | 39.05 |
| 2024-11-04 | 39.03 |
| 2024-11-01 | 39.38 |
| 2024-10-31 | 38.96 |
| 2024-10-30 | 39.43 |
| 2024-10-29 | 41.34 |
| 2024-10-28 | 41.47 |
| 2024-10-25 | 41.23 |
| 2024-10-24 | 41.62 |
| 2024-10-23 | 41.38 |
| 2024-10-22 | 41.71 |
| 2024-10-21 | 41.56 |
| 2024-10-18 | 41.46 |
| 2024-10-17 | 41.08 |
| 2024-10-16 | 41.49 |
| 2024-10-15 | 41.67 |
| 2024-10-14 | 41.55 |
| 2024-10-11 | 41.60 |
| 2024-10-10 | 41.30 |
| 2024-10-09 | 41.27 |
| 2024-10-08 | 40.62 |
| 2024-10-07 | 40.78 |
| 2024-10-04 | 41.10 |